Group 3C: HER2+ and HER2-low Metastatic Breast Cancer; Antibody-drug Conjugates; Treatment Resistance
The 2025 San Antonio Breast Cancer Symposium (SABCS) is a global meeting that highlights clinical, translational, and basic breast cancer research. It’s a unique opportunity for advocates to join the conversation. Prefer a different time? These same posters will be discussed in another session. Click to join Group 4A instead. Register Below This SABCS25 […]

